Golforoush, Pelin
Schneider, Michael D. http://orcid.org/0000-0001-9645-1938
Funding for this research was provided by:
Wellcome Trust (WT10638, WT205256)
Article History
Received: 29 October 2019
Accepted: 6 February 2020
First Online: 6 March 2020
Competing interests
: M.D.S. declares patent applications relating to MAP4K4 as a druggable target in human cardiac muscle cell death (UK Patent Applications 1716867.5, WO/2019/073253; 1819839.0; 1905472.5; 1905476.6). P.G. has no conflict of interest to disclose.